ANIK
Price
$9.07
Change
-$0.05 (-0.55%)
Updated
Oct 3 closing price
Capitalization
130.77M
24 days until earnings call
RVTY
Price
$94.05
Change
+$2.59 (+2.83%)
Updated
Oct 3 closing price
Capitalization
10.92B
29 days until earnings call
Interact to see
Advertisement

ANIK vs RVTY

Header iconANIK vs RVTY Comparison
Open Charts ANIK vs RVTYBanner chart's image
Anika Therapeutics
Price$9.07
Change-$0.05 (-0.55%)
Volume$221.38K
Capitalization130.77M
Revvity
Price$94.05
Change+$2.59 (+2.83%)
Volume$1.29M
Capitalization10.92B
ANIK vs RVTY Comparison Chart in %
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIK vs. RVTY commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIK is a StrongBuy and RVTY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ANIK: $9.07 vs. RVTY: $94.05)
Brand notoriety: ANIK and RVTY are both not notable
ANIK represents the Pharmaceuticals: Generic, while RVTY is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANIK: 165% vs. RVTY: 108%
Market capitalization -- ANIK: $130.77M vs. RVTY: $10.92B
ANIK [@Pharmaceuticals: Generic] is valued at $130.77M. RVTY’s [@Medical Specialties] market capitalization is $10.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.89B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B. The average market capitalization across the [@Medical Specialties] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIK’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 1 green FA rating(s).

  • ANIK’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 1 green, 4 red.
According to our system of comparison, RVTY is a better buy in the long-term than ANIK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIK’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • ANIK’s TA Score: 5 bullish, 3 bearish.
  • RVTY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANIK is a better buy in the short-term than RVTY.

Price Growth

ANIK (@Pharmaceuticals: Generic) experienced а +0.55% price change this week, while RVTY (@Medical Specialties) price change was +11.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.32%. For the same industry, the average monthly price growth was +8.33%, and the average quarterly price growth was +36.25%.

Reported Earning Dates

ANIK is expected to report earnings on Oct 30, 2025.

RVTY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Medical Specialties (+3.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($10.9B) has a higher market cap than ANIK($131M). RVTY YTD gains are higher at: -15.559 vs. ANIK (-44.897). RVTY has higher annual earnings (EBITDA): 822M vs. ANIK (-2.24M). RVTY has more cash in the bank: 992M vs. ANIK (53.2M). ANIK has less debt than RVTY: ANIK (25M) vs RVTY (3.38B). RVTY has higher revenues than ANIK: RVTY (2.8B) vs ANIK (115M).
ANIKRVTYANIK / RVTY
Capitalization131M10.9B1%
EBITDA-2.24M822M-0%
Gain YTD-44.897-15.559289%
P/E RatioN/A39.77-
Revenue115M2.8B4%
Total Cash53.2M992M5%
Total Debt25M3.38B1%
FUNDAMENTALS RATINGS
ANIK vs RVTY: Fundamental Ratings
ANIK
RVTY
OUTLOOK RATING
1..100
7917
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9787
PRICE GROWTH RATING
1..100
6557
P/E GROWTH RATING
1..100
7494
SEASONALITY SCORE
1..100
1950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (21) in the Medical Specialties industry is significantly better than the same rating for ANIK (92) in the Pharmaceuticals Other industry. This means that RVTY’s stock grew significantly faster than ANIK’s over the last 12 months.

RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ANIK (100) in the Pharmaceuticals Other industry. This means that RVTY’s stock grew similarly to ANIK’s over the last 12 months.

RVTY's SMR Rating (87) in the Medical Specialties industry is in the same range as ANIK (97) in the Pharmaceuticals Other industry. This means that RVTY’s stock grew similarly to ANIK’s over the last 12 months.

RVTY's Price Growth Rating (57) in the Medical Specialties industry is in the same range as ANIK (65) in the Pharmaceuticals Other industry. This means that RVTY’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as RVTY (94) in the Medical Specialties industry. This means that ANIK’s stock grew similarly to RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIKRVTY
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 6 days ago
63%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 11 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GUSH24.930.53
+2.17%
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF
KNGZ35.970.17
+0.46%
FirstTrust S&P500 DvrsDiv AristocratsETF
OOSB18.15N/A
N/A
One+One S&P 500 and Bitcoin ETF
IGOV42.59-0.02
-0.05%
iShares International Treasury Bond ETF
EMOT24.01-0.13
-0.55%
First Trust S&P 500 Economic Moat ETF

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-0.55%
RVTY - ANIK
39%
Loosely correlated
+2.83%
AVNS - ANIK
35%
Loosely correlated
+4.06%
ACRS - ANIK
34%
Loosely correlated
+1.09%
FLGT - ANIK
32%
Poorly correlated
-0.52%
ORGO - ANIK
32%
Poorly correlated
+1.42%
More